How much funding has Gleamer raised?

Gleamer has raised $40.3M in total funding, most recently a Series B round.

Who are Gleamer's investors?

Gleamer's investors include Supernova, Elaia, Heal Capital, XAnge.

Where is Gleamer headquartered?

Gleamer is headquartered in Paris, France.

What industry is Gleamer in?

Gleamer operates in Artificial Intelligence, Healthcare.

Gleamer

Medical-Grade AI for Radiology

Paris, France · Founded 2017 · $40.3M raised

Artificial Intelligence

Healthcare

Headquarters: Paris
Employees: 51–200
Founded: 2017
Business Model: B2B

Website: gleamer.ai
Total Funding: $40.3M
Last Round: $29.5M Series BJun 2023
Rounds: 3

About

Gleamer is a French medtech company founded in 2017 in Paris by Christian Allouche, Alexis Ducarouge, and Dr. Nor-Eddine Regnard, developing AI-powered clinical solutions to assist radiologists across all major imaging modalities including X-ray, CT, mammography, and MRI. The company's flagship platform, Gleamer Copilot, integrates directly into existing RIS and PACS environments to enable worklist prioritization, AI-assisted reporting, and semi-automated pre-diagnosis, helping radiologists detect pathologies faster and with greater confidence. Gleamer's solutions are CE- and FDA-cleared and used across more than 2,500 clinical sites in 45+ countries processing over 45 million exams per year; the company was acquired by RadNet's DeepHealth subsidiary in March 2026 for approximately €230M (~$270M USD).

Summary

Gleamer is an Artificial Intelligence company based in Paris, France, founded in 2017. It has raised $40.3M in total across 3 rounds, most recently a $29.5M Series B round in Jun 2023. Investors include Supernova, Elaia and Heal Capital.